EXECUTIVE ENGAGEMENTS
OUTREACH
606
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
121
Interactions with Platform & by Email
PARTICIPANTS
24
Unique # Participated
VALIDATIONS
12
Responses Validated*
COMPETITORS
33
Responses Validated*
BRANDS
0
Responses Validated*
* Login for a full stack data experience
DATE
FEB 2021
TABLES
216
PAGES
279
EDITION
7
PRICE
USD $5600
HIGHLIGHTS
Amid the COVID-19 crisis, the global market for Life Science Tools estimated at US$49.9 Billion in the year 2020, is projected to reach a revised size of US$82.4 Billion by 2027, growing at a CAGR of 7.4% over the analysis period 2020-2027. Cell Biology, one of the segments analyzed in the report, is projected to record a 7.3% CAGR and reach US$31.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Genomic segment is readjusted to a revised 7.5% CAGR for the next 7-year period.
The Life Science Tools market in the U.S. is estimated at US$13.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$18.3 Billion by the year 2027 trailing a CAGR of 11.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.1% and 6.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.
In the global Proteomics segment, USA, Canada, Japan, China and Europe will drive the 7.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$6.4 Billion in the year 2020 will reach a projected size of US$10.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$11.3 Billion by the year 2027, while Latin America will expand at a 9.4% CAGR through the analysis period.
SELECT PLAYERS
Agilent Technologies; Becton, Dickinson and Company; Bio-Rad Laboratories, Inc.; Bruker Corporation; Danaher Corporation; GE Healthcare; Hitachi, Ltd.; Hoffmann-La Roche Ltd.; Illumina, Inc.; Merck KGaA; Oxford Instruments plc; Qiagen N.V.; Shimadzu Corporation; Thermo Fisher Scientific, Inc.; ZEISS International
SEGMENTS
» Technology (Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies, Other Technologies) » End-Use (Healthcare, Biopharmaceutical Companies, Government & Academic, Other End-Uses)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Impact of Covid-19 and a Looming Global Recession |
| Global Competitor Market Shares |
| Life Science Tools Competitor Market Share Scenario Worldwide (in %): 2020E |
| Global Competitor Market Shares by Segment |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Life Science Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Life Science Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cell Biology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Genomic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Genomic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Genomic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Lab Supplies & Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Lab Supplies & Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Lab Supplies & Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Government & Academic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Government & Academic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Government & Academic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| USA Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| EUROPE |
| Market Facts & Figures |
| Europe Current & Future Analysis for Life Science Tools by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Life Science Tools by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| SPAIN |
| Spain Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Spain Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Spain Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Spain 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| RUSSIA |
| Russia Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Russia Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Russia Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Russia 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Life Science Tools by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Life Science Tools by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| AUSTRALIA |
| Australia Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Australia Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Australia Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Australia 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| INDIA |
| India Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| India Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| India Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| India 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| SOUTH KOREA |
| South Korea Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| South Korea Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| South Korea Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| South Korea 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF ASIA-PACIFIC |
| Rest of Asia-Pacific Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Rest of Asia-Pacific Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Asia-Pacific Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Asia-Pacific 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| LATIN AMERICA |
| Latin America Current & Future Analysis for Life Science Tools by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Life Science Tools by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Latin America Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Latin America Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Latin America 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| ARGENTINA |
| Argentina Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Argentina Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Argentina Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Argentina 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| BRAZIL |
| Brazil Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Brazil Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Brazil Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Brazil 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| MEXICO |
| Mexico Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Mexico Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Mexico Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Mexico 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF LATIN AMERICA |
| Rest of Latin America Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Rest of Latin America Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Latin America Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Latin America 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| MIDDLE EAST |
| Middle East Current & Future Analysis for Life Science Tools by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Life Science Tools by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Middle East Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Middle East Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Middle East 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| IRAN |
| Iran Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Iran Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Iran Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Iran 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| ISRAEL |
| Israel Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Israel Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Israel Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Israel 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| SAUDI ARABIA |
| Saudi Arabia Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Saudi Arabia Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Saudi Arabia Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Saudi Arabia 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| UNITED ARAB EMIRATES |
| UAE Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| UAE Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| UAE Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| UAE 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF MIDDLE EAST |
| Rest of Middle East Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Rest of Middle East Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Rest of Middle East Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Rest of Middle East 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| AFRICA |
| Africa Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Life Science Tools by Technology - Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Sales for Cell Biology, Genomic, Proteomics, Lab Supplies & Technologies and Other Technologies for the Years 2012, 2020 & 2027 |
| Africa Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR |
| Africa Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR |
| Africa 15-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Sales for Healthcare, Biopharmaceutical Companies, Government & Academic and Other End-Uses for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 33 |
